Article
FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung.
Cancer research - 2 May 2023
Tomoshige Koichi, Stuart William D, Fink-Baldauf Iris M, Ito Masaoki, Tsuchiya Tomoshi, Nagayasu Takeshi, Yamatsuji Tomoki, Okada Morihito, Fukazawa Takuya, Guo Minzhe, Maeda Yutaka
Abstract excerpt
The endoderm-lineage transcription factor FOXA2 has been shown to inhibit lung tumorigenesis in in vitro and xenograft studies using lung cancer cell lines. However, FOXA2 expression in primary lung tumors does not correlate with an improved patient survival rate, and the functional role of FOXA2 in primary lung tumors remains elusive. To understand the role of FOXA2 in primary lung tumors in vivo, here, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
